WallStreetZenWallStreetZen

NASDAQ: MBAI
Check Cap Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their MBAI stock forecasts and price targets.

Forecast return on equity

Is MBAI forecast to generate an efficient return?

Forecast return on assets

Is MBAI forecast to generate an efficient return on assets?

Company
-3,799.21%
Industry
8.51%
MBAI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MBAI earnings per share forecast

What is MBAI's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$2.45

MBAI revenue forecast

What is MBAI's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0

MBAI vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
MBAI$1.87N/AN/A
PRPH$0.21N/AN/A
ADVB$0.42N/AN/A
NDRA$5.91$38.00+542.98%Buy
BIAF$1.50N/AN/A
View Top Diagnostic & Research Stocks

Check Cap Stock Forecast FAQ

What is MBAI's earnings growth forecast for 2025-2025?

(NASDAQ: MBAI) Check Cap's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Check Cap's earnings in 2025 is -$25,149,000.

In 2025, MBAI is forecast to generate -$14,323,018 in earnings, with the lowest earnings forecast at -$13,761,331 and the highest earnings forecast at -$14,744,283.

If you're new to stock investing, here's how to buy Check Cap stock.

What is MBAI's revenue growth forecast for 2025-2025?

(NASDAQ: MBAI) Check Cap's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Check Cap's revenue in 2025 is $0.

In 2025, MBAI is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is MBAI's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: MBAI) forecast ROA is -3,799.21%, which is lower than the forecast US Diagnostics & Research industry average of 8.51%.

What is MBAI's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: MBAI) Check Cap's current Earnings Per Share (EPS) is -$4.30. In 2025, MBAI's EPS is forecast to hit -$2.45 (min: -$2.35, max: -$2.52).

What is MBAI's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: MBAI) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.